EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.
about
Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivoRole of EZH2 in cancer stem cells: from biological insight to a therapeutic target.Role of ARPC2 in Human Gastric Cancer.Ezh2, a novel target in detection and therapy of breast cancer.KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth.Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran.Inhibition of enhancer of zeste homolog 2 increases the expression of p16 and suppresses the proliferation and migration of ovarian carcinoma cells in vitro and in vivo.
P2860
Q33865244-D99F1AFF-C8A9-48A3-AE28-CBE95D280B73Q33914216-491526BC-19CF-4EB6-9E6B-1101DA497F84Q38697602-5C8A0709-B736-419E-93DA-F3EAB935AB47Q42345199-402E20BD-E624-4821-95E9-C7E473558EFEQ49201007-E4C07875-48E1-46FE-8F35-5C643ACB0BBAQ49344192-F4B2A954-5ED6-4925-98CD-CDB84600A557Q49777893-1A3CE03F-03C8-4C91-B6F9-4A5DBF8DDC45
P2860
EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
EZH2 overexpression in differe ...... th clinicopathologic features.
@en
type
label
EZH2 overexpression in differe ...... th clinicopathologic features.
@en
prefLabel
EZH2 overexpression in differe ...... th clinicopathologic features.
@en
P2093
P2860
P1433
P1476
EZH2 overexpression in differe ...... th clinicopathologic features.
@en
P2093
Joseph Rohr
Shirong Ma
Shuangping Guo
Yingmei Wang
P2860
P2888
P356
10.1186/S13000-016-0491-5
P577
2016-04-26T00:00:00Z
P6179
1012145202